226 related articles for article (PubMed ID: 11321130)
1. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.
Centanni S; Santus P; Casanova F; Di Marco F; Brazzola G; Canonica GW
Drugs Exp Clin Res; 2000; 26(4):133-8. PubMed ID: 11109513
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
4. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
Virchow JC; Prasse A; Naya I; Summerton L; Harris A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
[TBL] [Abstract][Full Text] [Related]
6. [Influence of zafirlukast on pulmonary functions and quality of life in patients with asthma].
Xiang XD; Zhou R; Chen Y
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):251-3. PubMed ID: 12536697
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
Brabson JH; Clifford D; Kerwin E; Raphael G; Pepsin PJ; Edwards LD; Srebro S; Rickard K
Am J Med; 2002 Jul; 113(1):15-21. PubMed ID: 12106618
[TBL] [Abstract][Full Text] [Related]
9. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
Nathan RA; Bleecker ER; Kalberg C;
Am J Med; 2001 Aug; 111(3):195-202. PubMed ID: 11530030
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
[TBL] [Abstract][Full Text] [Related]
11. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
[TBL] [Abstract][Full Text] [Related]
12. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
[TBL] [Abstract][Full Text] [Related]
13. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT).
Korenblat PE; Kemp JP; Scherger JE; Minkwitz MC; Mezzanotte W
Ann Allergy Asthma Immunol; 2000 Feb; 84(2):217-25. PubMed ID: 10719780
[TBL] [Abstract][Full Text] [Related]
14. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.
Yurdakul AS; Calişir HC; Tunçtan B; Ogretensoy M
Respir Med; 2002 May; 96(5):322-9. PubMed ID: 12113382
[TBL] [Abstract][Full Text] [Related]
15. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
Adkins JC; Brogden RN
Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
[TBL] [Abstract][Full Text] [Related]
16. Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study.
Huang CJ; Wang CH; Liu WT; Yang MC; Lin HC; Yu CT; Shiao CJ; Tan CC; Yang CK; Kuo HP
Chang Gung Med J; 2003 Aug; 26(8):554-60. PubMed ID: 14609035
[TBL] [Abstract][Full Text] [Related]
17. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.
Nathan RA; Minkwitz MC; Bonuccelli CM
Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315
[TBL] [Abstract][Full Text] [Related]
19. Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.
Kemp JP; Korenblat PE; Scherger JE; Minkwitz M
J Fam Pract; 1999 Jun; 48(6):425-32. PubMed ID: 10386485
[TBL] [Abstract][Full Text] [Related]
20. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
